Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F08%3A00104181" target="_blank" >RIV/00216208:11140/08:00104181 - isvavai.cz</a>
Alternative codes found
RIV/00669806:_____/08:00002174 RIV/00064211:_____/08:#0000028 RIV/00216208:11120/08:00001313
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study
Original language description
Authors compared chemonaive elderly patients treated by either gefitinib or vinorelbine. Non inferiority of both adents compared to each other was considered.
Czech name
Gefitinib versus vinorelbin u chemoterapie - naivních starších nemocných s pokročilým nemalobuněčným karcinomem plic (INVITE). Randomizovaná studie
Czech description
Autoři porovnávali účinnost léčby gefitinibu či vinorelbinu u chemonaivních starších nemocných. Non Inferiorita obou léčebných režimů byla touto studií prokázána.
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FP - Other medical fields
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2008
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Clinical Oncology
ISSN
0732-183X
e-ISSN
—
Volume of the periodical
26
Issue of the periodical within the volume
26
Country of publishing house
US - UNITED STATES
Number of pages
8
Pages from-to
—
UT code for WoS article
000259350400006
EID of the result in the Scopus database
—